DKSH Holding AG (DKSH) AI Stock Analysis

• Market Cap: CHF3.82B
• Dividend Yield: 4%
• Average Volume (3M): 88.08K
• Price to Earnings (P/E): 19.6
• Beta (1Y): 0.90
• Revenue Growth: 2.66%
• EPS Growth: 2.91%
• Country: CH
• Employees: 26,167
• Sector: Services
• Sector Strength: N/A
• Industry: Consulting Services
• EPS (TTM): 1.41
• Shares Outstanding: 65,042,960
• 10 Day Avg. Volume: 94,303
• 30 Day Avg. Volume: 88,080
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: CHF77.67
• Price Target Upside: 32.09% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 4

• Rating: 68 Neutral
• Price Target: CHF65.00 ▲(10.54% Upside)

DKSH Holding AG scores well due to its strong financial performance, characterized by stable revenue growth and efficient cash flow management. The technical analysis indicates a downtrend with potential oversold conditions, which might present opportunities for value investors. The valuation is supported by a solid dividend yield, though the P/E ratio suggests fair valuation. The absence of recent earnings call data or corporate events means these factors do not influence the current analysis.

DKSH Holding AG Business Overview & Revenue Model

Company Description

DKSH Holding AG provides various market expansion services in Thailand, Greater China, Malaysia, Singapore, rest of the Asia Pacific, and internationally. The company offers sourcing, marketing, sales, distribution, and after-sales services. It operates through four segments: Healthcare, Consumer Goods, Performance Materials, and Technology. The Healthcare segment provides various services, such as registration, regulatory, market entry studies, importation, customs clearance, marketing and sales, physical distribution, invoicing, and cash collection services for ethical pharmaceuticals, consumer health, and over-the-counter health products, as well as medical devices. The Consumer Goods segment offers a range of services, including product feasibility studies, registration, importation, customs clearance, marketing and merchandising, sales, warehousing, physical distribution, invoicing, cash collection, and after-sales services for fast moving consumer goods, food services, luxury goods, and fashion and lifestyle products, as well as hair and skin cosmetics. The Performance Materials segment sources, markets, and distributes a range of specialty chemicals and ingredients for the pharmaceutical, personal care, food and beverage, and industrial applications, as well as provides market expansion services for performance materials. The Technology segment offers market expansion services comprising a range of capital investment goods and analytical instruments in the areas of infrastructure, industrial materials and supplies, precision and textile machinery, semiconductors, photovoltaic and electronics, agriculture, and hospitality, as well as specialized industrial applications. The company was founded in 1865 and is based in Zurich, Switzerland.

How the Company Makes Money

DKSH generates revenue primarily through its Market Expansion Services, which include a variety of key offerings such as sales and marketing, distribution, logistics, and other value-added services. The company operates in multiple sectors, allowing for diversified revenue streams from consumer goods, healthcare products, and performance materials. Key revenue streams include service fees for distribution and logistics, commissions from sales, and direct sales of products in certain markets. Additionally, DKSH has formed significant partnerships with various global brands and manufacturers, enhancing its market reach and operational efficiency, which in turn contributes to its earnings and growth.

DKSH Holding AG Financial Statement Overview

Summary

DKSH Holding AG demonstrates a strong financial position with stable revenue growth, improved profit margins, and efficient cash flow management. The company has managed to enhance equity and reduce leverage, contributing to financial stability. Despite minor fluctuations in free cash flow, the company maintains a healthy cash generation capability, indicating robust operational performance.

Income Statement

DKSH Holding AG shows a stable revenue base with a slight revenue growth from 2023 to 2024. The gross profit margin improved significantly due to higher gross profit, indicating better cost management or pricing strategy. Despite consistent revenue, net profit margin has increased, indicating improved operational efficiency. EBIT and EBITDA margins are stable, reflecting consistent operational performance.

Balance Sheet

The company's debt-to-equity ratio has decreased, signifying reduced leverage, which enhances financial stability. Stockholders' equity has increased, indicating a stronger equity base. Return on Equity (ROE) is improving, showing better profitability on equity. The equity ratio remains solid, further supporting the company's stable financial position.

Cash Flow

DKSH's operating cash flow remains strong, highlighting robust cash generation from operations. The free cash flow growth rate is slightly negative, indicating a minor decline in free cash flow. However, the operating cash flow to net income ratio is healthy, demonstrating efficient cash conversion from earnings. Overall, cash flow management appears strong.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	11.09B	11.07B	11.32B	11.11B	10.74B
Gross Profit	1.64B	759.70M	792.80M	770.50M	716.30M
EBITDA	472.00M	440.60M	437.30M	460.60M	371.00M
Net Income	214.80M	182.00M	201.10M	223.90M	157.10M
Balance Sheet
Total Assets	5.85B	5.47B	5.88B	5.35B	5.12B
Cash, Cash Equivalents and Short-Term Investments	609.10M	687.20M	636.40M	673.70M	680.80M
Total Debt	839.80M	958.20M	1.01B	587.10M	565.60M
Total Liabilities	3.97B	3.73B	4.05B	3.46B	3.32B
Stockholders Equity	1.82B	1.69B	1.76B	1.81B	1.74B
Cash Flow
Free Cash Flow	321.30M	340.80M	237.00M	338.20M	289.60M
Operating Cash Flow	362.90M	393.10M	321.90M	393.20M	325.30M
Investing Cash Flow	-75.60M	-116.50M	-511.80M	-147.90M	-103.20M
Financing Cash Flow	-364.20M	-185.20M	180.70M	-239.50M	-113.40M

DKSH Holding AG Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 58.80
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:DKSH, the sentiment is Neutral. The current price of 58.8 is above the 20-day moving average (MA) of 57.71, below the 50-day MA of 59.68, and below the 200-day MA of 63.79, indicating a neutral trend. The MACD of -0.20 indicates Negative momentum. The RSI at 52.21 is Neutral, neither overbought nor oversold. The STOCH value of 71.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CH:DKSH.

DKSH Holding AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SFSN	71 Outperform	CHF4.27B	18.12		1.83%	-0.71%	-6.12%
KNIN	70 Outperform	CHF19.33B	16.71		5.07%	13.42%	1.21%
ADEN	70 Outperform	CHF4.29B	15.76		3.91%	-4.68%	-5.79%
DKSH	68 Neutral	CHF3.82B	19.55		4.00%	2.66%	2.91%
SGSN	67 Neutral	CHF15.84B	24.67		3.92%	3.12%	11.70%
Sector *	56 Neutral	$13.94B	13.68	10.03%	0.85%	7.13%	-12.93%
0QLH	―	CHF7.12B	11.50	22.69%	―	―	―

DKSH Holding AG Corporate Events

DKSH Acquires Eppendorf’s Thailand Operations, Strengthening Scientific Solutions Portfolio

DKSH has announced an agreement to acquire Eppendorf’s direct business in Thailand, enhancing its position as a leading scientific solutions provider in Asia. This move allows DKSH to distribute Eppendorf’s products in Thailand, expanding its reach in high-growth sectors like food & beverage, biotech, and pharma. The acquisition reflects a trend of multinational companies outsourcing to focus on core capabilities, benefiting DKSH’s market expansion strategy.

The most recent analyst rating on (CH:DKSH) stock is a Buy with a CHF80.00 price target. To see the full list of analyst forecasts on DKSH Holding AG stock, see the CH:DKSH Stock Forecast page.

DKSH Reports Strong H1 2025 Results with Core EBIT Growth

DKSH Holding AG reported a 5.1% increase in Core EBIT to CHF 169.3 million and a 2.1% rise in net sales to CHF 5.5 billion for the first half of 2025, despite global economic uncertainties. The company announced five acquisitions and maintained strong free cash flow, reinforcing its resilient business model and confirming its positive outlook for 2025, driven by strategic execution and market expansion, particularly in Asia Pacific.

The most recent analyst rating on (CH:DKSH) stock is a Buy with a CHF80.00 price target. To see the full list of analyst forecasts on DKSH Holding AG stock, see the CH:DKSH Stock Forecast page.

DKSH Expands Market Reach with APN Plastics Acquisition

DKSH Performance Materials has announced the acquisition of APN Plastics, a specialty polymers distributor with operations in Australia and Malaysia. This strategic move is set to enhance DKSH’s market presence in these regions by integrating APN Plastics’ established customer base and technical expertise in sectors like medical and engineering plastics. The acquisition aligns with DKSH’s growth strategy, aiming to expand its capabilities and market reach in the Asia Pacific region, potentially benefiting stakeholders through increased business opportunities and market expansion.

The most recent analyst rating on (CH:DKSH) stock is a Buy with a CHF75.00 price target. To see the full list of analyst forecasts on DKSH Holding AG stock, see the CH:DKSH Stock Forecast page.